SCHEMBL1735065

SCHEMBL1735065

O=C1CO[C@H]2[C@@H]1OC[C@@H]2O

nearest known ligand 0.44

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.44
LMNA P02545 1/20 0.44
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL196060 1.00 THRB (0.44) THRBLMNAMAPT
SCHEMBL10016808 1.00 THRB (0.44) THRBLMNAMAPT
SCHEMBL15218988 1.00 THRB (0.44) THRBLMNAMAPT
SCHEMBL10048336 1.00 THRB (0.44) THRBLMNAMAPT
Isosorbide SCHEMBL699485 0.96 THRB (0.52) THRBLMNAMAPT
SCHEMBL10552467 0.75 THRB (0.41) THRBLMNAMAPT
SCHEMBL24621340 0.74
SCHEMBL372212 0.74 THRB (0.44) THRBLMNA
SCHEMBL8293189 0.74 THRB (0.44) THRBLMNA
SCHEMBL10016807 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018112774-A1 PROCESS FOR PREPARING ISOMANNIDE, MONOKETONES AND MIXTURES THEREOF RHODIA OPERATIONS (FR) 2018-06-28 WO disclosed
US-8841096-B2 Method for producing multicyclical ring systems carrying amino groups EVONIK DEGUSSA GMBH (DE) 2014-09-23 US disclosed
US-8378127-B2 Method for producing 2,6-dioxabicyclo-(3.3.0)-octane-4,8-dione EVONIK DEGUSSA GMBH (DE) 2013-02-19 US disclosed
US-8378127-B2 Method for producing 2,6-dioxabicyclo-(3.3.0)-octane-4,8-dione EVONIK DEGUSSA GMBH (DE) 2013-02-19 US disclosed
US-20120041216-A1 METHOD FOR PRODUCING MULTICYCLICAL RING SYSTEMS CARRYING AMINO GROUPS EVONIK DEGUSSA GMBH (DE) 2012-02-16 US disclosed
US-20120041216-A1 METHOD FOR PRODUCING MULTICYCLICAL RING SYSTEMS CARRYING AMINO GROUPS EVONIK DEGUSSA GMBH (DE) 2012-02-16 US disclosed
EP-2143751-B1 Polycarbonate and method for producing the same TOYOTA CHUO KENKYUSHO KK (JP) 2011-11-16 EP disclosed
US-20110269977-A1 METHOD FOR PRODUCING 2,6-DIOXABICYCLO-(3.3.0)-OCTANE-4,8-DIONE EVONIK DEGUSSA GMBH (DE) 2011-11-03 US disclosed
US-20110269977-A1 METHOD FOR PRODUCING 2,6-DIOXABICYCLO-(3.3.0)-OCTANE-4,8-DIONE EVONIK DEGUSSA GMBH (DE) 2011-11-03 US disclosed
WO-2011131885-A1 GEOTHERMAL FACILITY WITH THERMAL RECHARGING OF THE SUBSOIL BSR TECHNOLOGIES (FR) 2011-10-27 WO disclosed
EP-2143751-A1 Polycarbonate and method for producing the same Kabushiki Kaisha Toyota Chuo Kenkyusho (JP) 2010-01-13 EP disclosed
EP-0230557-A2 2,6-Dioxabicyclo[3.3.0]octane derivatives, their preparation and use as medicament Heinrich Mack Nachf. (DE) 1987-08-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120041216-A1 METHOD FOR PRODUCING MULTICYCLICAL RING SYSTEMS CARRYING AMINO GROUPS AKR7A2, AADAT, OAT THRB 3156/4885LMNA 2418/4885MAPT 3409/4885
US-20110269977-A1 METHOD FOR PRODUCING 2,6-DIOXABICYCLO-(3.3.0)-OCTANE-4,8-DIONE HAO2, HK2, UGT8 THRB 2260/4885LMNA 2973/4885MAPT 4384/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.